Intra-Cellular Therapies, Inc. Announces Multiple Presentations On ITI-007 At The 4th Biennial Schizophrenia International Research Society (SIRS) Conference
4/7/2014 9:02:56 AM
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders has presented several posters and a talk at the 4th Biennial Schizophrenia International Research Society (SIRS) conference being held in Florence, Italy.
Help employers find you! Check out all the jobs and post your resume.
comments powered by